ADMELOG is a rapid-acting human insulin analog indicated to improve glycemic control in adults with type 2 diabetes and adults and children (3 years and older) with type 1 diabetes.

For complete information, visit Sanofi

Device Type:
Insulin Pen
Reusable Disposable:
Medicine Type:


Insulin Type:
Rapid Acting
Dose Delivery:

Injection: 100 units/mL (U-100) is available as:

  • 10 mL multiple-dose vials
  • 3 mL multiple-dose vials
  • 3 mL single-patient-use SoloStar® prefilled pens
Total Capacity:

300 units

Memory Function:
Audible Click:
Assistive Dexterity Issue Options:

  • The dosage of ADMELOG must be individualized based on the route of administration and the individual's metabolic needs, blood glucose monitoring results and glycemic control goal.
  • ADMELOG administered by subcutaneous injection should generally be used in regimens with intermediate or long-acting insulin.

The Danatech Digest

Join 18,000+ professionals who get our latest diabetes technology updates



This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.

ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.